来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置首页>技术资料首页>行业动态>公司动态>Seegene与Hamilton合作开发MDx系统Seegene Inks MOU With Hamilton

Seegene与Hamilton合作开发MDx系统Seegene Inks MOU With Hamilton

来自官方2017年10月20日 10:43 点击:976

Seegene random access system

随机存取系统

Seegene
1.jpg

韩国公司Seegene今天宣布它已签署了一份谅解备忘录,与Hamilton进一步发展Seegene随机存取系统(Seegene random access system)。

Seegene random access system是一种可在当天提供结果的分子诊断解决方案。该系统包含了一个通用的核酸提取协议,可应用于包括血液、尿液、粪便和痰液在内的各种不同样本。Seegene称,这些功能将应用在Hamilton公司液体处理平台上的多重实时PCR检测中。

该公司还注意到,它计划通过与汉弥尔顿合作完成其数字化开发系统的开发。完成数字化开发系统将使初始试剂的自动化成为随机存取系统的最终质量控制。

“在我们的系统建成后,分子诊断的利用率将大大提高,因为当天的订单报告允许医院进行分子诊断,这也将率先实现实时个性化病人护理的突破。”Seegene创始人兼首席执行官Jong Yoon Chun在一份声明中说。


2.jpg

去年,Seegene曾与西班牙的InstitutCatalàd'Oncologia公司合作,使用临床标本对其诊断产品进行研究。

Korean firm Seegene announced today that it has signed a memorandum of understanding with Hamilton to further develop the Seegene random access system.

The random access system is a molecular diagnostics solution that provides results within the same day. The system incorporates a universal nucleic acid extraction protocol which can be applied to a variety of samples, including blood, urine, stool, and sputum. These capabilities will be enabled through the partnership by integrating simultaneous and high multiplex real-time PCR testing on Hamilton's liquid handling platforms, Seegene said.

The firm also noted that it plans to complete the development of its digitalized development system through the collaboration with Hamilton. Finishing the digitalized development system will enable automation of initial reagent development to final quality control for the random access system.

"With the completion of [our] system, molecular diagnostics utilization will greatly increase as order-to-report on the same day allows hospitals to conduct molecular diagnosis, [which] will lead to a breakthrough in achieving on-time customized patient care," Seegene Founder and CEO Jong Yoon Chun said in a statement.  

Last year, the South Korean company partnered with Spain's InstitutCatalàd'Oncologia to conduct studies of its diagnostic products using clinical specimens.


(来源: 来自官方 )


全年征稿 / 资讯合作

联系邮箱:kefu@labbase.net

版权与免责声明

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.labbase.net,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。